Ginkgo Bioworks DNA Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's common stock, shares, outstanding?
- Ginkgo Bioworks (DNA) reported common stock, shares, outstanding of $61.66M in Q1 2026.
- How has Ginkgo Bioworks's common stock, shares, outstanding changed year-over-year?
- Ginkgo Bioworks's common stock, shares, outstanding increased by 12.7% year-over-year, from $54.7M to $61.66M.
- What is the long-term trend for Ginkgo Bioworks's common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Ginkgo Bioworks's common stock, shares, outstanding has grown at a -46.2% compound annual growth rate (CAGR), from $1.29B to $58.21M.